Want to see APNHY full AI Analyst Report?

Aspen Pharmacare (APNHY) Financial Statements

25 Followers

Aspen Pharmacare Financial Overview

Aspen Pharmacare's market cap is currently $4.33B. The company's EPS TTM is $5.87; its P/E ratio is 26.34; and it has a dividend yield of 1.26%. Aspen Pharmacare is scheduled to report earnings on September 2, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Jun 26	Jun 25	Jun 24	Jun 23	Jun 22
Income Statement
Total Revenue	Rs 34.14B	Rs 43.36B	Rs 44.71B	Rs 40.71B	Rs 38.61B
Gross Profit	Rs 13.76B	Rs 19.13B	Rs 19.42B	Rs 18.41B	Rs 18.31B
Operating Income	Rs 5.29B	Rs 1.44B	Rs 7.00B	Rs 7.82B	Rs 8.67B
EBITDA	Rs 7.16B	Rs 2.16B	Rs 9.90B	Rs 10.19B	Rs 9.93B
Net Income	Rs 2.59B	Rs -1.08B	Rs 4.40B	Rs 5.23B	Rs 6.49B
Balance Sheet
Cash & Short-Term Investments	Rs 15.87B	Rs 6.41B	Rs 12.34B	Rs 10.91B	Rs 6.18B
Total Assets	Rs 107.41B	Rs 135.89B	Rs 139.16B	Rs 134.28B	Rs 111.38B
Total Debt	Rs 15.44B	Rs 36.12B	Rs 36.46B	Rs 29.28B	Rs 22.25B
Net Debt	Rs -425.58M	Rs 29.71B	Rs 24.12B	Rs 18.37B	Rs 16.06B
Total Liabilities	Rs 27.68B	Rs 51.00B	Rs 54.29B	Rs 48.05B	Rs 40.43B
Stockholders' Equity	Rs 79.73B	Rs 84.89B	Rs 84.86B	Rs 86.24B	Rs 70.94B
Cash Flow
Free Cash Flow	Rs 4.63B	Rs 104.00M	Rs 690.00M	Rs 2.34B	Rs 2.68B
Operating Cash Flow	Rs 6.73B	Rs 5.16B	Rs 6.22B	Rs 5.52B	Rs 5.37B
Investing Cash Flow	Rs 23.83B	Rs -5.22B	Rs -9.47B	Rs -3.42B	Rs -2.16B
Financing Cash Flow	Rs -20.86B	Rs -162.00M	Rs 3.62B	Rs -420.00M	Rs -4.68B

Currency in ZAR

Aspen Pharmacare Earnings and Revenue History

Income Statement >

Aspen Pharmacare Debt to Assets

Balance Sheet >

Aspen Pharmacare Cash Flow

Cash Flow >

Aspen Pharmacare Forecast EPS vs Actual EPS

Earnings >